Associated Banc Corp Vertex Pharmaceuticals Inc Transaction History

Associated Banc Corp

$3.2 Billion
Q2 2024

A detailed history of Associated Banc Corp transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Associated Banc Corp holds 9,481 shares of VRTX stock, worth $4.76 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

9,481

Previous 9,624 1.49%

Holding current value

$4.76 Million

Previous $4.02 Million 10.47%

% of portfolio

0.14%

Previous 0.13%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$392.81 - $485.53 $56,171 - $69,430	-143 Reduced 1.49%	9,481 $4.44 Million
Q1 2024 May 09, 2024	SELL	$407.69 - $446.08 $53,407 - $58,436	-131 Reduced 1.34%	9,624 $4.02 Million
Q4 2023 Feb 09, 2024	SELL	$343.0 - $410.68 $33,957 - $40,657	-99 Reduced 1.0%	9,755 $3.97 Million
Q3 2023 Nov 09, 2023	SELL	$338.18 - $362.46 $16,232 - $17,398	-48 Reduced 0.48%	9,854 $3.43 Million
Q2 2023 Aug 07, 2023	BUY	$314.42 - $351.91 $1,572 - $1,759	5 Added 0.05%	9,902 $3.48 Million
Q1 2023 May 09, 2023	SELL	$283.23 - $323.1 $228,566 - $260,741	-807 Reduced 7.54%	9,897 $3.12 Million
Q4 2022 Feb 10, 2023	SELL	$285.76 - $321.48 $57,723 - $64,938	-202 Reduced 1.85%	10,704 $3.09 Million
Q3 2022 Nov 09, 2022	SELL	$273.83 - $305.53 $33,133 - $36,969	-121 Reduced 1.1%	10,906 $3.16 Million
Q2 2022 Aug 10, 2022	SELL	$234.96 - $292.55 $105,262 - $131,062	-448 Reduced 3.9%	11,027 $3.11 Million
Q1 2022 May 11, 2022	SELL	$221.42 - $260.97 $2.02 Million - $2.38 Million	-9,122 Reduced 44.29%	11,475 $3 Million
Q4 2021 Feb 10, 2022	SELL	$177.01 - $223.45 $970,014 - $1.22 Million	-5,480 Reduced 21.01%	20,597 $4.52 Million
Q3 2021 Nov 08, 2021	SELL	$181.39 - $202.99 $722,294 - $808,306	-3,982 Reduced 13.25%	26,077 $4.73 Million
Q2 2021 Aug 11, 2021	BUY	$187.49 - $221.1 $4.17 Million - $4.91 Million	22,225 Added 283.7%	30,059 $6.06 Million
Q1 2021 May 05, 2021	SELL	$207.02 - $241.31 $13.6 Million - $15.9 Million	-65,697 Reduced 89.35%	7,834 $1.86 Million
Q4 2020 Feb 11, 2021	BUY	$207.01 - $276.09 $6.71 Million - $8.95 Million	32,417 Added 78.85%	73,531 $17.4 Million
Q3 2020 Nov 12, 2020	BUY	$255.65 - $303.1 $6.05 Million - $7.18 Million	23,680 Added 135.83%	41,114 $11.2 Million
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $2.16 Million - $2.84 Million	9,595 Added 122.4%	17,434 $5.06 Million
Q1 2020 May 14, 2020	BUY	$199.77 - $247.81 $1.57 Million - $1.94 Million	7,839 New	7,839 $1.87 Million

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Associated Banc Corp, based on Form 13F filings with the SEC.

News

Stay updated on Associated Banc Corp with notifications on news.

Account

Associated Banc Corp Vertex Pharmaceuticals Inc Transaction History